Markets.com Logo

KNOS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.0039$
  • Previous Close
    0.0038$
  • 52 Week Change
    0.01$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.0016$ - 0.0135$
  • Dividend Per Share
    0
  • Market cap
    2 901 K$
  • EPS
    -0.01
  • Beta
    1.364
  • Volume
    --

About

KNOS.US represents the common stock of Knopp Biosciences Inc., a privately held drug discovery and development company focused on delivering innovative therapeutics for autoimmune and neurological diseases with high unmet needs. They are primarily involved in discovering and developing small molecule drugs. Their lead clinical stage product is dexpramipexole, being investigated for the treatment of hypereosinophilic syndromes. Knopp Biosciences' stock is traded on the OTC Markets Group's OTCQB Venture Market.

Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence

Noah Lee|--

Global Markets Show Resilience Amidst Iran Conflict, But Underlying Risks Persist

Emma Rose|--

Iran War Threatens US Labor Market's 'Wonderful Balance': A Deep Dive

Emma Rose|--

Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment

Sophia Claire|--

US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks

Sophia Claire|--

Global Debt Crisis Deepens Amidst Iran Conflict and Fiscal Fragility

Ava Grace|--

Apple's Strategic Pivot: MacBook Neo, Supply Chain Tactics, and Foldable Phone Hurdles

Emma Rose|--

Factors

Company Performance: Revenue growth, profitability, and successful drug development progress strongly influence investor confidence and stock price.

Industry Trends: Overall market sentiment towards biotechnology and pharmaceutical sectors impacts KNOS.US stock. Positive industry reports and favorable regulatory changes can increase demand.

Clinical Trial Results: Positive data from clinical trials of KNOS.US's drug candidates boosts investor enthusiasm. Negative or inconclusive results often lead to a stock price decline.

Regulatory Approvals: FDA approval of a KNOS.US drug significantly impacts its potential revenue and valuation, causing stock price surges. Delays or rejections have the opposite effect.

Competition: Competitor activities, including successful drug launches and promising clinical trial outcomes, can negatively impact KNOS.US's market share and stock price.

Market Conditions: Broader economic conditions, interest rates, and overall market volatility affect investor risk appetite and stock valuations, impacting KNOS.US along with other companies.

News and Events: Company announcements, press releases, and major healthcare conferences influence investor perceptions and trading activity, affecting stock price movements.

Investor Sentiment: Positive analyst ratings, media coverage, and social media trends can drive demand and increase KNOS.US stock price, while negative sentiment can cause price declines.

Partnerships and Collaborations: Strategic partnerships and collaborations with other companies can enhance KNOS.US's prospects and boost investor confidence, positively influencing stock price.

Management Team: The experience, expertise, and reputation of the management team can affect investor confidence and impact the stock's valuation.

People Also Watch

Latest news

Close Coordination Between Israel and US on Iran Nuclear Talks Highlighted

Noah Lee|--

US-Iran Talks Show Progress Towards Ceasefire Framework Agreement

Liam James|--

Federal Reserve Independence Under Historic Test: Navigating Democratic Legitimacy and Political Pressure

Liam James|--

Latest Education Articles

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Julian Parker|--
Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Julian Parker|--
Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Frances Wang|--
Recommended Topics